Эффективность комбинированной противовирусной терапии у больных с компенсированным циррозом печени в исходе хронического гепатита с
Н. Н. Николаева, Е Г Грищенко, Л. В. Николаева et al. · Siberian medical review · 2012
An integrated study of 31 patients with compensated cirrhosis (5 points on the H-P) in the outcome of chronic hepatitis C (CHC) was conducted, 21 of them (group 1) had combined antiviral therapy. 10 patients (control group) received no treatment etiotrop. The study shows that in compensated liver cirrhosis in the outcome of chronic hepatitis C with combination antiviral therapy can be achieved SVR 42.9% of patients with genotype 1b, which is only 10% less than the frequency of HCV-infection eradication under CHC. This is implemented to reduce the risk of decompensation of cirrhosis, development of hepatocellular carcinoma and the onset of liver death.
Cited by 0 works.